Skip to contentClarengateINTELLIGENCE
Companies/14714531

Ensocell Ltd

Research and experimental development on biotechnology · Cambridge

ActiveUnited KingdomIncorporated 2023Private Limited Company
Register Ask analyst

Financial position

Accounts to 2026-03-31 · GBP · company scope

Net assets
£2,867,369
Cash
£6,759,399
Turnover
—
Profit / loss
—
Current assets
£11,057,042
Creditors < 1 year
£715,364
Equity
£2,867,369
Average employees
0.15

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

4 periods
Reported figures2026-03-31GBP · company2025-03-31GBP · company2024-09-30GBP · company2024-03-31GBP · unknown
Balance sheet
Net assets£2,867,369£8,513,278£1,813,481£1,011,331
Equity£2,867,369£8,513,278£1,813,481£1,011,331
Assets
Property, plant & equipment£655,421£428,241£355,989£436,434
Current assets£11,057,042£8,304,439£1,637,361£650,760
Cash at bank£6,759,399£6,581,807£907,593£514,867
Debtors£4,297,643£1,722,632£729,768£135,893
Liabilities
Creditors within one year£715,364£125,577£179,869£75,863
Creditors after one year£8,129,730£93,825——
Net current assets£10,341,678£8,178,862£1,457,492£574,897
Assets less current liabilities£10,997,099£8,607,103£1,813,481£1,011,331
People
Average employees0.150.0755
Source evidenceView filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

1 outstanding charges
Fixed · created 2023-12-11
—
Outstanding